![]()
|
Report Date : |
01.04.2008 |
IDENTIFICATION
DETAILS
|
Name : |
MERIDIAN MEDICARE LIMITED |
|
|
|
|
Registered Office : |
Village Shamti, Solan, 173212, Himachal Pradesh. |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as on) : |
31.03.2006 |
|
|
|
|
Date of Incorporation : |
10.06.1997 |
|
|
|
|
Com. Reg. No.: |
020064 |
|
|
|
|
CIN No.: [Company
Identification No.] |
U24231HP1997PLC020064 |
|
|
|
|
TAN No.: [Tax
Deduction & Collection Account No.] |
PTLM11669A |
|
|
|
|
Legal Form : |
Closely held Public Limited Liability Company |
|
|
|
|
Line of Business : |
Manufacturing and Marketing of Medicines. |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 63120 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a well established and reputed Company having Satisfactory
track. Trade relations are fair. Business is active. Payments are reported as
usually correct and as per Commitments. The Company can be considered normal for business dealings at usual
trade terms and conditions. |
LOCATIONS
|
Registered Office / Factory : |
Village Shamti, Solan, 173212, Himachal Pradesh, India. |
|
Tel. No.: |
91-1792-229739, 229779 |
|
Fax No.: |
91-1792-229839 |
|
E-Mail : |
|
|
Website : |
DIRECTORS
|
Name : |
Mr. Vinod Gupta |
|
Designation : |
Managing Director |
|
Address : |
Surya Nagar, Chauhan Building, Rajgarh Road, Solan, 173212, Himachal
Pradesh, , India. |
|
Date of Birth/Age : |
22/04/1943 |
|
Date of Appointment : |
01.10.2007 |
|
|
|
|
Name : |
Mrs. Madhu Gupta |
|
Designation : |
Whole-time Director |
|
Address : |
Surya Nagar, Chauhan Building, Rajgarh Road, Solan, 173212, Himachal
Pradesh, India. |
|
Date of Birth/Age : |
13/05/1947 |
|
Date of Appointment : |
01.10.2007 |
|
|
|
|
Name : |
Mr. Suresh Kumar Chaudhary |
|
Designation : |
Whole-time director |
|
Address : |
1082, DLF Colony, Ward-23, Rohtak, 124001, Haryana, India. |
|
Date of Birth/Age : |
02/06/1950 |
|
Date of Appointment : |
01.10.2007 |
|
|
|
|
Name : |
Mr. Satinder Singh |
|
Designation : |
Whole-time Director |
|
Address : |
6, Village Aanji, H.No. 622, Tehsil, Solan, 173212, Himachal Pradesh,
India. |
|
Date of Birth/Age : |
20/12/1956 |
|
Date of Appointment : |
01.10.2007 |
|
|
|
|
Name : |
Mr. Vikas Agarwal |
|
Designation : |
Whole-time Director |
MAJOR SHAREHOLDERS
/ SHAREHOLDING PATTERN
As on 30.09.2006
|
Names of Shareholders |
No. of Shares |
|
Mr. Sumit Gupta |
200 |
|
Mrs. Madhu Gupta |
3500 |
|
Mr. Arun Trehan |
400 |
|
Mrs. Sangeeta Trehan |
100 |
|
Mr. Shiv Kumar Khosla |
400 |
|
Mr. Jagmohan Malhotra |
100 |
|
Mrs. Rashmi Khosla |
100 |
|
Mr. Suresh Kumar Chaudhary |
3100 |
|
Mr. Vinod Gupta |
29100 |
|
Mrs. Shalika Agarwal |
3000 |
|
Mr. Prem Vati |
10000 |
|
Total |
50000 |
Equity Share breakup (Percentage of Total Equity)
As on 31.03.2006
|
Sr. No. |
Category |
Percentage |
|
1. |
Directors or relatives of directors. |
97.8 |
|
2. |
Other top 5 Share Holders (Other than those
listed above) |
2.2 |
|
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturing and Marketing of Medicines. |
|
|
|
|
Products : |
Alimentry System 1.Antacid, Anti-ulcerantes 2. GIT regulators, Anti-flatulence 3. Antispasmodics 4. Laxatives and Purgatives 5. Anti-diarrhoea 6. Anti emetic 7. ORS Powder Cardiovascular
System: 1.Anti Anginal drugs 2. Calcium channel Blockers 3. Diuretics Respiratory System: 1.Anti asthmatic Preparations 2. Cough and cold remedies Neuro-Muscular
System 1.Analgesic and Antipyretics 2. Anti inflammatory enzymes 3. Anti rheumatic, Anti-inflammatory, Analgesics 4. Minor Tranquilizers 5. Anti emetic drugs 6. Anti depressant 7. Muscle relaxants Antibiotics: 1. Tetracycline 2. Ciprofloxacin 3. Norfloxacin 4. Anti bacterial combinations 5. Anti fungal 6. Aminoglycosides 7. Quinolones 8. Other antibiotics Other
Chemo-therapeutics: 1. Anti amoebic 2. Anti helmintic 3. Anti viral 4. Anti septic Genito Urinary
Track system 1. Urinary Antiseptics 2. Urinary Infection antibiotics 3. Preparation for Vaginal Infection 4. For erectile dysfunction Vitamins and
minerals: 1 Vitamin B / with C 2. Vitamin C 3. Vitamin and Calcium 4. Multi Vitamins with Minerals 5. Pediatrics Dry Syp, Vitamins and Minerals 6. Anti anemic and Pre & Post natal vitamins Allergy and Immune
System: 1. Anti histaminics 17. Anti allergics |
PRODUCTION STATUS
|
Particulars |
Actual
Production |
|
Tablet |
144 million |
|
Capsules |
72 million ton |
|
Liquids External Preparations |
0.360 million
Litre |
|
Powder |
6.25 million
pouches |
GENERAL
INFORMATION
|
Bankers : |
v ABN AMRO Bank v Baghat Urban
Co-op Bank Limited, Solan - 173212 v HDFC Bank,
Chandigarh v HDFC Bank, Solan v State Bank of
India, Solan |
|
|
|
|
Banking
Relations : |
Satisfactory |
|
|
|
|
Auditors : |
|
|
Name : |
Jagmohan Chohda and Company, Chartered Accountant |
|
Address : |
Near LIC Building, The Mall, Solan, 172312, Himachal Pradesh, India. |
CAPITAL STRUCTURE
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
250,000 |
Equity Shares |
Rs. 10/- Each |
Rs. 2.500 millions |
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
50,000 |
Equity Shares |
Rs. 10/- Each |
Rs. 0.500
million |
FINANCIAL DATA
[all figures are in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2006 |
31.03.2005 |
31.03.2004 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
0.500 |
0.500 |
0.500 |
|
|
2] Share Application Money |
0.000 |
1.070 |
0.000 |
|
|
3] Reserves & Surplus |
15.280 |
3.884 |
0.569 |
|
|
4] (Accumulated Losses) |
0.000 |
0.000 |
0.000 |
|
|
NETWORTH |
15.780 |
5.454 |
1.069 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
1.770 |
1.837 |
0.673 |
|
|
2] Unsecured Loans |
0.350 |
0.535 |
0.586 |
|
|
TOTAL BORROWING |
2.120 |
2.372 |
1.259 |
|
|
DEFERRED TAX LIABILITIES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
17.900 |
7.826 |
2.328 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
10.027 |
6.721 |
2.985 |
|
|
Capital work-in-progress |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
INVESTMENT |
1.800 |
0.000 |
0.000 |
|
|
DEFERREX TAX ASSETS |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
24.785
|
11.031 |
0.000 |
|
|
Sundry Debtors |
11.045
|
4.682 |
0.000 |
|
|
Cash & Bank Balances |
6.072
|
2.200 |
0.000 |
|
|
Other Current Assets |
0.000
|
0.000 |
0.000 |
|
|
Loans & Advances |
1.254
|
0.200 |
8.862 |
|
Total
Current Assets |
43.156
|
18.113 |
8.862 |
|
|
Less : CURRENT LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Current Liabilities |
35.798
|
16.678 |
9.527 |
|
|
Provisions |
1.291
|
0.337 |
0.000 |
|
Total
Current Liabilities |
37.089
|
17.015 |
9.527 |
|
|
Net Current Assets |
6.067
|
1.098 |
(0.665) |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.006 |
0.007 |
0.008 |
|
|
|
|
|
|
|
|
TOTAL |
17.900 |
7.826 |
2.328 |
|
PROFIT & LOSS
ACCOUNT
|
PARTICULARS |
31.03.2006 |
31.03.2005 |
31.03.2004 |
|
|
Sales Turnover |
172.596 |
69.029 |
12.952 |
|
|
Other Income |
0.110 |
0.455 |
1.058 |
|
|
Total Income |
172.706 |
69.484 |
14.010 |
|
|
|
|
|
|
|
|
Profit/(Loss) Before Tax |
12.736 |
3.667 |
0.586 |
|
|
Provision for Taxation |
1.072 |
0.287 |
0.062 |
|
|
Profit/(Loss) After Tax |
11.664 |
3.380 |
0.524 |
|
|
|
|
|
|
|
|
Expenditures : |
|
|
|
|
|
|
Raw Material Consumed |
136.736 |
52.085 |
0.000 |
|
|
Material and Factory Expenses |
0.000 |
0.000 |
10.868 |
|
|
Consumption of stores and spares parts |
5.178 |
2.017 |
0.000 |
|
|
Salaries, Wages, Bonus, etc. |
7.734 |
3.956 |
0.000 |
|
|
Managerial Remuneration |
0.240 |
0.240 |
0.000 |
|
|
Selling and Distribution Expenses |
0.000 |
0.000 |
0.149 |
|
|
Payment to Auditors |
0.005 |
0.005 |
0.000 |
|
|
Interest |
0.238 |
0.203 |
0.000 |
|
|
Insurance Expenses |
0.055 |
0.052 |
0.000 |
|
|
Personal Expenses |
0.000 |
0.000 |
0.859 |
|
|
Financial Expenses |
0.000 |
0.000 |
0.157 |
|
|
Power & Fuel |
0.298 |
0.071 |
0.000 |
|
|
Depreciation & Amortization |
1.499 |
1.594 |
0.623 |
|
|
Other Expenditure |
7.987 |
5.594 |
0.766 |
|
Total Expenditure |
159.970 |
65.817 |
13.423 |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2006 |
31.03.2005 |
31.03.2004 |
|
PAT / Total
Income |
(%) |
6.75
|
5.28 |
3.74 |
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
7.38
|
5.31 |
4.52 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
7.37
|
5.28 |
4.18 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.81
|
0.67 |
0.55 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
2.35
|
3.12 |
8.91 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
1.16
|
1.06 |
0.93 |
LOCAL AGENCY
FURTHER INFORMATION
|
This form is for |
Creation of Charge |
|
Corporation identity number (CIN) or foreign company registrations number of the company |
U24231HP1997PLC020064 |
|
Name of the company |
MERIDIAN MEDICARE LIMITED |
|
Address |
Village Shamti, Solan, 173212, Himachal Pradesh, India. |
|
Type of Charges |
Others |
|
Whether consortium finance is involved |
No |
|
Whether joint charge involved |
No |
|
Number of charge holder(s) |
1 |
|
Particular of the charge holder |
Name : Directors of Industries City : Solan State : Himachal Pradesh ISO Country Code : IN Pin Code : 173211 e-mail ID : info@merimed.com |
|
Nature or description of the instrument creating or modifying the charge |
v Agreement of Hypothecation for Central Investment Subsidy v Agreement for availing Central Investment Subsidy. v No objection letter from Bhagat Urban Co-operative Bank Limited, Solan for ceding first pari passu charge in favour of G.M. DIC, Solan |
|
Date of the instrument creating charge |
23.03.2007 |
|
Whether charge created or modified outside India |
No |
|
Amount Secure by the charge |
Rs. 972.381 millions |
|
Brief particulars of the principal terms and conditions and extent and operation of the charge |
(d) Extent and operation of the charge The charge shall rank pari passu with the charge of Bhagat Urban Co-operative Bank Limited, Solan |
|
Short particulars of the Property charged |
Machinery and Equipment situated at the factory site of the company at Village Shamti, Solan, Himachal Pradesh. |
|
Whether any of the property or interest therein under reference is not registered in the name of the company |
No |
Form 8
|
Name of the company |
M/s MERIDIAN
MEDICARE LIMITED |
|
Presented By |
Mr. Vinod Gupta,
Director |
|
1) Date and description of instrument creating the change |
17.04.2003 : Agreement for Cash Credit / Overdraft |
|
2) Amount secured by the charge/amount owing on the securities of charge |
Rs. 0.600 millions |
|
3) Short particular of the property charged. If the property acquired is subject to charge, date of the acquired of the property should be given |
General lien and right of set of and combine account without notice and charge on all movable property of every description coming into the possession and control of the said bank on account of the borrowers or any one of them or for the time being held by the said bank on behalf , of the borrowers or any one of them whether alone or jointly with others in India or elsewhere including without prejudice to this generality, any moneys, bank drafts, deposits, deposit receipts for moneys, promissory notes, bills of exchange, cheques, hundies, stocks and shares, goods and merchandise, bills of lading, railway receipts, lorry receipts, government bills with inspection notes and other bills in course of collection and other documents of title of immovable property and mercantiles documents of every description including hire-purchase agreement or contracts, (other than those affecting immovable property and requiring registration under law relating to registration) and other documents evidencing the title of the borrowers as creditors or members of any corportation association, registered society, company or syndicate in India or elsewhere. |
|
4) Gist of the terms and conditions and extent and operation of the charge. |
Rate of Interest: Interest shall be charged at 15 percent per annum subject to the change in interest rates made by the Reserve Bank of India from time to time. Repayable on demand. Extent and operation of charge: 100%. |
|
5) Name and Address and description of the person entitled to the charge. |
The Baghat Urban Co-operative Bank Limited Solan – 173212, (H.P.) |
Form 8 Particular for creation or modification of charges
|
Name of the company |
M/s MERIDIAN
MEDICARE LIMITED |
|
Presented By |
Mr. Vinod Gupta,
Director |
|
1) Date and description of instrument creating the change |
08.11.2004 v Term Loan Agreement dated 08.11.2004 v Deed of Hypothecation dated 08.11.2004 |
|
2) Amount secured by the charge/amount owing on the securities of charge |
Rs. 1.000 millions |
|
3) Short particular of the property charged. If the property acquired is subject to charge, date of the acquired of the property should be given |
Land and Machinery Purchased from/out of the advance made by the Bank. |
|
4) Gist of the terms and conditions and extent and operation of the charge. |
Rate of Interest: Interest shall be charged at 12.50 % per annum or as per RBI Directors / Bank rules. Repayment : Repayable in 120 monthly Instalments of Rs. 14000/- starting from 08.12.2004 Extent and operation of charge : 100% |
|
5) Name and Address and description of the person entitled to the charge. |
The Baghat Urban Co-operative Bank Limited, Solan – 173212, (H.P.) |
Fixed Assets:
v Land and Building
v Vehicles
v Furniture and Fixtures
v Car
v Water Tank
v Plant and Machinery
v EPABX
v Computers
v Laboratory Equipments
COMPANY PROFILE:
Subject is in the service of society by manufacturing
and marketing quality medicines since 1988. Shri Vinod Gupta who has 25 years
experience of marketing pharmaceutical products and 18 years experience in
manufacturing quality medicines promoted the Company.
Initially the products were manufactured and
marketed by the name of Meridian Laboratories Pvt. Ltd established at Saproon
(Solan) in the year 1987. The new unit has been established at Shamti, 5 Km.
from Solan, on Rajgarh Road by the name of Meridian Medicare Ltd in the year
2002.
The unit has three sections and manufactures
products in the forms of Tablets, Capsules and Syrups. The unit is set up in
pristine surroundings of the Shivalik foothills in Himachal Pradesh and has
been built and equipped keeping in view the requirements laid down by GMP and
Schedule M (revised) of the Drugs & Cosmetics Act, 1940. They hold GMP
certification as well as ISO 9001:2000 certificate.
The packing and designs of products are very
sophisticated and of highest standards. The products are well accepted by
Medical fraternity, sold all over India, and supplied to various Government
Institutions, health clinics and hospitals.
PRODUCTION LINES
AND SECTIONS:
The factory has
three production lines in three sections:.
. Tablet – Two
Sections (Betalactum and Non Betalactum)
. Capsule – Two
Sections (Betalactum and Non Betalactum)
. Syrup – Two
Sections (Oral and External Applications)
CMT REPORT
(Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts, India Prisons Service,
Interpol, etc.
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
The market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE
GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
The Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE
RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs. 40.02 |
|
UK Pound |
1 |
Rs. 78.77 |
|
Euro |
1 |
Rs. 62.97 |
SCORE & RATING
EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
5 |
|
PAID-UP CAPITAL |
1~10 |
5 |
|
OPERATING SCALE |
1~10 |
5 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
6 |
|
--PROFITABILIRY |
1~10 |
4 |
|
--LIQUIDITY |
1~10 |
5 |
|
--LEVERAGE |
1~10 |
5 |
|
--RESERVES |
1~10 |
5 |
|
--CREDIT LINES |
1~10 |
5 |
|
--MARGINS |
-5~5 |
|
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
45 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history (10%) Market trend (10%) Operational size
(10%)
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, they have no basis upon which to
recommend credit dealings |
No Rating |
|